Skip to Main Content

Paper Details

Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer.
Cancer Cell
55
2018
Author NameAffiliation
Yi-Hsin Elsa HsuThe University of Texas MD Anderson Cancer Center
Mien-Chie HungThe University of Texas MD Anderson Cancer Center, USA Center for Molecular Medicine and Graduate Institute of Biomedical Sciences, China Medical University, Asia University
  • 1 - 2

Datasets

Release 1.2